NEOCHEMICAL Trademark

Trademark Overview


On Tuesday, July 19, 2005, a trademark application was filed for NEOCHEMICAL with the United States Patent and Trademark Office. The USPTO has given the NEOCHEMICAL trademark a serial number of 79016306. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, July 20, 2015. This trademark is owned by NEOCHEMICAL DESARROLLOS AVANZADOS, S.A.. The NEOCHEMICAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal /diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective ...
neochemical

General Information


Serial Number79016306
Word MarkNEOCHEMICAL
Filing DateTuesday, July 19, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, July 20, 2015
Registration Number3187604
Registration DateTuesday, December 19, 2006
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 3, 2006

Trademark Statements


Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Description of the Colors ClaimedThe color blue appears in all the letters and the geometric shape forming in the letter "O".
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal /diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of yeast infections; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations for use in smoking cessation preparations; pharmaceutical preparations for use in tissue and skin repair preparations; pharmaceutical preparations for use in acne medication; pharmaceutical preparations for use in allergy medication; pharmaceutical preparations for use in antacids; pharmaceutical preparations for use in anthelmintics; pharmaceutical preparations for use in antiarrhythmics; pharmaceutical preparations for use in antibiotics; pharmaceutical preparations for use in anticoagulants; pharmaceutical preparations for use in anticonvulsants; pharmaceutical preparations for use in antidepressants; pharmaceutical preparations for use in antiemetics; pharmaceutical preparations for use in antiflatulants; pharmaceutical preparations for use in antihistamines; pharmaceutical preparations for use in antihypertensives; pharmaceutical preparations for use in anti-infectives; pharmaceutical preparations for use in anti-inflammatories; pharmaceutical preparations for use in antiparasitics; pharmaceutical preparations for use in antibacterials; pharmaceutical preparations for use in antifungals; pharmaceutical preparations for use in antivirals; pharmaceutical preparations for use in burn relief medication; pharmaceutical preparations for use in calcium channel blockers; pharmaceutical preparations for use in central nervous system depressants; pharmaceutical preparations for use in central nervous system stimulants; pharmaceutical preparations for use in cough treatment medication; pharmaceutical preparations for use in diarrhea medication; pharmaceutical preparations for use in gastrointestinal medication; pharmaceutical preparations for use in glaucoma agents; pharmaceutical preparations for use in hydrocortisone; pharmaceutical preparations for use in hypnotic agents; pharmaceutical preparations for use in sedatives; pharmaceutical preparations for use in ophthalmic preparations; veterinary preparations, namely, antibiotics, antiparasitics, antiseptics, antimycotics, antihistamines, anti-inflammatories, local anaesthetics, biomaterials, veins therapeutics, antidiabetics, antirheumatics, moisturizers, analgesics, cortico steroids, vitamins, anti-asthmatics, cytostatics, vaccines, veterinary preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, Bluecomb, pneumonia; veterinary preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary preparations for the treatment of vitamin deficiencies; veterinary preparations for the treatment of nutritional muscular dystrophy; veterinary preparations for the treatment of arthritis, muscle soreness and sprains; veterinary preparations for udder care; veterinary preparations for the treatment of parasites; veterinary pharmaceuticals for parturition induction in swine; veterinary preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary preparations for the treatment of swine bacterial infectious diseases; veterinary preparations for the treatment of infectious diseases in poultry; veterinary preparations for respiratory and reproductive diseases in cattle; veterinary preparations for periodontal diseases; veterinary preparations for the treatment of bacterial infections in dogs; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, bandages for dressings; material for stopping teeth, dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides for agricultural use; sanitary sterilizing compositions; antiseptic preparations; disinfectant compositions for hygienic purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEOCHEMICAL DESARROLLOS AVANZADOS, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameNEOCHEMICAL DESARROLLOS AVANZADOS, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameNEOCHEMICAL DESARROLLOS AVANZADOS, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Friday, February 5, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 5, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 8, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 3, 2014GENERIC MADRID TRANSACTION SENT TO IB
Monday, November 3, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 27, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 27, 2013CANCELLED SECTION 71
Friday, December 21, 2012NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 25, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 25, 2007FINAL DISPOSITION PROCESSED
Tuesday, July 24, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 19, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, October 3, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2006NOTICE OF PUBLICATION
Saturday, August 5, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 4, 2006ASSIGNED TO LIE
Tuesday, July 18, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 24, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 26, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 26, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 16, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 16, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 3, 2006REFUSAL PROCESSED BY IB
Monday, February 13, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 10, 2006REFUSAL PROCESSED BY MPU
Thursday, February 9, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 8, 2006NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2006ASSIGNED TO EXAMINER
Thursday, November 10, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, November 3, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB